Comparative Pharmacodynamics and Plasma Concentrations of d-threo-Methylphenidate Hydrochloride After Single Doses of d-threo-Methylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in a Double-Blind, Placebo-Controlled, Crossover Laboratory School Study in Children With Attention-Deficit/Hyperactivity Disorder

Attention Deficit ◽

Plasma Concentrations ◽

Laboratory School ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

School Study

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s206020 ◽

2019 ◽

Vol Volume 15 ◽

pp. 1193-1209 ◽

Cited By ~ 4

Author(s):

Celestino Rodíguez ◽

Trinidad Garcia ◽

Debora Areces ◽

Estrella Fernández ◽

Marcelino García-Noriega ◽

...

Keyword(s):

Docosahexaenoic Acid ◽

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

6.16 Dasotraline in Children With Attention-Deficit/Hyperactivity Disorder (ADHD): Results of a Randomized, Double-Blind, Placebo-Controlled Study

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.361 ◽

2017 ◽

Vol 56 (10) ◽

pp. S281 ◽

Cited By ~ 1

Author(s):

Robert Goldman ◽

Lenard Adler ◽

Thomas J. Spencer ◽

Robert Findling ◽

Seth C. Hopkins ◽

...

Keyword(s):

Attention Deficit ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2019.0085 ◽

2020 ◽

Vol 30 (2) ◽

pp. 58-68

Author(s):

Ann C. Childress ◽

Scott H. Kollins ◽

Henry C. Foehl ◽

Jeffrey H. Newcorn ◽

Greg Mattingly ◽

...

Keyword(s):

Preschool Children ◽

Attention Deficit ◽

Extended Release ◽

Dose Titration ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Flexible Dose ◽

Titration Study

Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12913 ◽

2019 ◽

Vol 73 (11) ◽

pp. 690-696 ◽

Cited By ~ 5

Author(s):

Sara Dehbozorghi ◽

Sayna Bagheri ◽

Kamyar Moradi ◽

Kamyar Shokraee ◽

Mohammad‐Reza Mohammadi ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

EPA-0666 – Long-term maintenance of efficacy of extended-release guanfacine hydrochloride (GXR) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): double-blind, placebo-controlled, multicentre, phase 3 randomized withdrawal study

European Psychiatry ◽

10.1016/s0924-9338(14)78034-4 ◽

2014 ◽

Vol 29 ◽

pp. 1 ◽

Cited By ~ 3

Author(s):

J. Newcorn ◽

V. Harpin ◽

M. Huss ◽

M. Johnson ◽

J.A. Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit ◽

Extended Release ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Hyperactivity Disorder ◽

Term Maintenance

Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial

The International Journal of Neuropsychopharmacology ◽

10.1093/ijnp/pyv094 ◽

2015 ◽

Vol 19 (3) ◽

pp. pyv094 ◽

Cited By ~ 17

Author(s):

Hsiang-Yuan Lin ◽

Susan Shur-Fen Gau

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Functional Brain ◽

Hyperactivity Disorder ◽

Functional Brain Networks ◽

Atomoxetine Treatment

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

The World Journal of Biological Psychiatry ◽

10.3109/15622975.2011.600333 ◽

2011 ◽

Vol 14 (4) ◽

pp. 268-281 ◽

Cited By ~ 9

Author(s):

Miguel Casas ◽

Michael Rösler ◽

J. J. Sandra Kooij ◽

Ylva Ginsberg ◽

Josep Antoni Ramos-Quiroga ◽

...

Keyword(s):

Attention Deficit ◽

Fixed Dose ◽

Prolonged Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Dose Study

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

Child and Adolescent Psychiatry and Mental Health ◽

10.1186/1753-2000-3-17 ◽

2009 ◽

Vol 3 (1) ◽

Cited By ~ 74

Author(s):

Sharon B Wigal ◽

◽

Scott H Kollins ◽

Ann C Childress ◽

Liza Squires

Keyword(s):

Attention Deficit ◽

Laboratory School ◽

Lisdexamfetamine Dimesylate ◽

School Aged Children ◽

Hyperactivity Disorder ◽

School Study

A Randomized, Double-Blind, Placebo-Controlled Study of Atomoxetine in Japanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2008.0154 ◽

2009 ◽

Vol 19 (4) ◽

pp. 341-350 ◽

Cited By ~ 26

Author(s):

Michihiro Takahashi ◽

Yasushi Takita ◽

Kosuke Yamazaki ◽

Takashi Hayashi ◽

Hironobu Ichikawa ◽

...

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Controlled Study ◽

Japanese Children ◽

Double Blind ◽

Double Blind Placebo ◽